The European Brain Council (EBC) welcomes the first part of the EU Biotech Act as proposed by the European Commission. It is indeed regarded as timely initiative to strengthen Europe’s capacity to translate its excellence in science into tangible health solutions. In particular, its aims to strengthen the EU’s biotechnology and biomanufacturing ecosystem, with an initial and explicit focus on health biotechnology, [...]
The European Brain Council (EBC) Rare Disease Day Event convened clinicians, patients, policymakers, researchers and industry leaders to advance coordination on rare diseases in Europe. Building on the Rare Brain Disease (RBD) Ecosystem, the event sought to identify systemic gaps, strengthen research–care integration, and review EU regulatory and research developments. A key outcome was [...]
True to tradition, HjärnForum – the National Association for the Fight against Brain Diseases in collaboration with the Brain Council opens this year's Brain Week in Copenhagen on 9th March. The Danish Brain Council invites you to three exciting lectures about the brain, as well as a subsequent debate about the establishment of a [...]
Her Majesty Queen Letizia received this morning in audience at the Zarzuela Palace a delegation from the Spanish Brain Council (CEC), in an institutional meeting in which the entity presented the strategic advances developed in recent months in the field of research, brain health and international positioning of Spanish neuroscience. This event has allowed [...]
On 24 February 2026, the European Parliament Committee on Public Health (SANT) held a Public Hearing on ‘Brain health: Policy challenges and opportunities to manage neurological diseases’. The European Brain Council (EBC) was pleased to be invited to take part in this essential discussion through the contribution of its President-Elect, Professor Sameer Zuberi, as [...]
The European Brain Council (EBC), in collaboration with Neurofibromatosis Patients United (NFPU), is pleased to launch the 'Rethinking Neurofibromatosis Type 1' project on the occasion of EBC's Rare Disease Day event, held on February 24th, 2026 in Brussels. Neurofibromatosis is a rare genetic disease, that includes three different diseases that affect over 250,000 people [...]
The European Brain Council (EBC), in collaboration with the Institute of Management of Scuola Superiore de Sant'Anna, is pleased to launch the 'Rethinking Myasthenia Gravis' Advocacy Paper on the occasion of EBC's Rare Disease Day event, held on February 24th, 2026 in Brussels. Rethinking Myasthenia Gravis (MG) is a research-driven project that will offer [...]
Brussels, 24 February 2026 – Today, the European Parliament Committee on Public Health (SANT) will hold a Public Hearing on ‘Brain health: Policy challenges and opportunities to manage neurological diseases’. Brain disorders, neurological and mental alike, represent one of the most pressing health challenges facing the European Union. At least one in three Europeans [...]
As part of Brain Awareness Week 2026, the European Brain Council (EBC) joins the European Academy of Neurology (EAN) and the Federation of European Neuroscience Societies (FENS), within the Brain Health Mission and the support of MEP Angelika Winzig (AT, EPP), to hold a Brain Health Day: Prevention, Policy, Progress on 18 March 2026. [...]
Following our successful Poland Country Profile launch in June 2025, we are pleased to release the second instalment in the Rethinking Schizophrenia Country Profiles series: This time for Denmark. On 8 December 2025, the Danish Brain Council and the European Brain Council convened a webinar titled "A Comprehensive, High-Quality Approach to the Treatment of [...]
